Caffeine-containing drinks may help GI health

Drinking caffeinated beverages may benefit some people who are at
high-risk for liver disease, according to new research presented at
a conference on digestive disease running in New Orleans this week.

Researchers from the US National Institute of Diabetes and Digestive and Kidney Disease reported on a national, population-based study among almost 6,000 adults who were at high risk for liver injury due to excessive alcohol consumption, hepatitis B or C, obesity, or other factors.

The research (abstract 100766) showed an inverse correlation between coffee and caffeine consumption and liver injury, seen in around 8.7 per cent of this high-risk population, said the researchers.

Those who drank more than two cups of coffee per day were 44 per cent less likely to show evidence of liver damage compared to those who did not consume caffeinated drinks. The risk reduction seen with consumption of any caffeinated beverage was even higher, at 69 per cent.

Last year a Norwegian study found that drinking three cups of coffee daily may reduce the risk of mortality from liver cirrhosis.

Co-author of the new study Dr James Everhart said the results warranted further research, adding: "There is surprisingly little evidence-based information on the influence of diet and nutrition on the course and severity of chronic liver disease."

Additional studies presented at the conference​, including one linking soda consumption to the rise of esophageal cancer in the US, demonstrates the strong assocation between diet and health.

"The relationships between diet and disease that these investigators have seen are intriguing and should stimulate further exploration in this important area. It is even more apparent that lifestyle and dietary choices made during youth can have a significant impact on health later in life,"​ commented Lee Kaplan of Massachusetts General Hospital.

Related news

Show more

Related products

show more

BB536 for optimal Gut health and beyond

BB536 for optimal Gut health and beyond

Content provided by Morinaga Milk Industry Co., Ltd. | 03-Oct-2024 | White Paper

Among the various probiotics strains available, Bifidobacterium longum BB536 stands out due to its well-documented safety, efficacy, and regulatory approvals....

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Embrace Active Aging and ENJOY life!

Embrace Active Aging and ENJOY life!

Content provided by IFF | 05-Sep-2024 | Product Brochure

Live life to the fullest, regardless of age. Our science-backed formulas, packed with clinically studied probiotics and botanicals, empower you to age...

Giellepi finds evidence of bromelain adulteration

Giellepi finds evidence of bromelain adulteration

Content provided by Giellepi SpA | 03-Sep-2024 | Product Brochure

As demand for botanicals continues to increase, unethical suppliers try to maximize profitability offering adulterated raw materials.

Related suppliers

Follow us

Products

View more

Webinars